Detalles de la búsqueda
1.
Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation.
Liver Int
; 35(1): 176-83, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24649882
2.
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort.
BMC Gastroenterol
; 15: 97, 2015 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26239732
3.
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.
J Gastrointestin Liver Dis
; 25(1): 15-24, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27014750
4.
Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report.
J Med Case Rep
; 8: 257, 2014 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25047566
5.
Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.
Dig Liver Dis
; 46(1): 67-71, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24125691
6.
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trial.
Dig Liver Dis
; 45(4): 323-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23245590
7.
Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
Dig Liver Dis
; 46(1): 88-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24054768
8.
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
Transpl Int
; 20(7): 583-90, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17433090
Resultados
1 -
8
de 8
1
Próxima >
>>